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SUMMARY
In many tissues, homeostasis is maintained by phys-
ical contact between stem cells and an anatomically
defined niche. However, how stem cell homeostasis
is achieved in environments where cells are motile
and dispersed among their progeny remains un-
known. Using murine spermatogenesis as a model,
we find that spermatogenic stem cell density is
tightly regulated by the supply of fibroblast growth
factors (FGFs) from lymphatic endothelial cells. We
propose that stem cell homeostasis is achieved
through competition for a limited supply of FGFs.
We show that the quantitative dependence of stem
cell density on FGF dosage, the biased localization
of stem cells toward FGF sources, and stem cell
dynamics during regeneration following injury
can all be predicted and explained within the frame-
work of a minimal theoretical model based on
‘‘mitogen competition.’’ We propose that this model
provides a generic and robustmechanism to support
stem cell homeostasis in open, or facultative, niche
environments.
INTRODUCTION
The maintenance of cycling adult tissues relies on the activity of
stem cell populations. To replenish cells lost through differentia-
tion, stem cells must balance self-renewal and differentiation
(Krieger and Simons, 2015; Simons and Clevers, 2011). Such
fate asymmetry may be enforced at the level of individual cell di-
visions or may be assigned stochastically with balance achieved
only at the population level—termed ‘‘population asymmetry’’
(Klein and Simons, 2011). Traditionally, efforts to resolve the fac-
tors that control fate asymmetry place emphasis on short-range
mitogenic and anti-differentiation signals from a definitive
anatomical niche, a specialized microenvironment to which
stem cells anchor, becoming physically separated from their
differentiating progeny (Morrison and Spradling, 2008; Stine
and Matunis, 2013; Watt and Hogan, 2000). However, in some
tissues, such as mammalian blood and spermatogenesis, stem
cell maintenance is thought to take place in a ‘‘facultative,’’ or
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‘‘open,’’ niche (Morrison and Spradling, 2008; Stine andMatunis,
2013; Yoshida, 2018a), where stem cells are often highly motile
and lie dispersed among their differentiating progeny. The ques-
tion of how stem cell number is regulated in such environments is
poorly understood.
In the mouse testis, the vast stem cells that support long-term
homeostasis are included within the population of GFRa1+ sper-
matogonia, which comprise mononucleated (Asingle [As]) and
syncytial (Apair [Apr] and Aaligned [Aal]) cells (Garbuzov et al.,
2018; Hara et al., 2014; Hofmann et al., 2005). Whether the
self-renewing compartment comprises all or a subset of this
population remains unclear (Lord and Oatley, 2017; Yoshida,
2018b). Although some propose that long-term self-renewal po-
tential is restricted to a small subpopulation of GFRa1+ As cells
expressing Id4 or other markers (Chan et al., 2014; Helsel
et al., 2017), others argue that the entire GFRa1+ population
comprises a single pool in which cells interconvert between
topologically distinct states of As and Apr/Aal syncytia (Hara
et al., 2014). Nevertheless, during homeostasis, it is known that
the size of the GFRa1+ pool is kept constant through population
asymmetry, in which continuous and stochastic stem cell loss
through differentiation is locally compensated by proliferation
of neighbors (Hara et al., 2014; Klein et al., 2010; Klein and
Simons, 2011). However, the mechanisms that ensure this bal-
ance remain undefined.
In the definitive, or closed, niche environment of Drosophila
and C. elegans gonads, self-renewal-promoting signals show a
restricted distribution (Spradling et al., 2011). In mouse seminif-
erous tubules, factors known to regulate stem cell behavior (i.e.,
self-renewal-promoting glial cell line-derived neurotrophic factor
[GDNF], the GFRa1 ligand [Chen et al., 2016; Meng et al., 2000],
and differentiation-promoting retinoic acid [RA] and Wnt) are
distributed in a spatially uniformmanner around the tubule, while
showing periodic temporal variation in concert with the seminif-
erous epithelial cycle (Sato et al., 2011; Sharma andBraun, 2018;
Takase and Nusse, 2016; Tokue et al., 2017; Vernet et al., 2006;
Ikami et al., 2015; Oakberg, 1956; Yoshida, 2018a). However,
GFRa1+ cells show biased localization toward the vasculature
(arterioles and venules) and surrounding interstitium; yet the ba-
sis of this localization is unknown (Chiarini-Garcia et al., 2001;
Hara et al., 2014; Yoshida et al., 2007). Despite such a bias,
GFRa1+ cells are not clustered in defined regions but disperse
among their differentiation-primed (NGN3+/RARg+/Miwi2+) and
committed (KIT+) progeny and show persistent and activemigra-
tion on the basement membrane along and between different
vasculature-associated regions (Figures 1A–1D and S1A; Ikami
et al., 2015; Carrieri et al., 2017; Hara et al., 2014), emphasizing
the non-canonical and open nature of the niche environment in
this tissue. Strikingly, despite local fluctuations, the GFRa1+
cell density averaged over tubular segments is remarkably con-
stant both spatially (Figures 1B, 1C, and S1A; Hara et al., 2014)
and temporally (remaining constant even across the 8.6-day
seminiferous epithelial cycle; Grasso et al., 2012; Ikami et al.,
2015). This suggests that the pool size regulation of GFRa1+ cells
is achieved in a manner that stabilizes their average density.
In this study, we report on how fibroblast growth factor (FGF)
family ligands, secreted from a subset of lymphatic endothelial
(LE) cells near the vascular network of arterioles and venules
and accompanying interstitium, serve as critical extracellular
factors that regulate GFRa1+ cell density homeostasis. By
analyzing the population dynamics of GFRa1+ spermatogonia
in wild-type (WT) and mutant mice, under both normal and per-
turbed conditions, we present evidence that competition for a
limited supply of mitogens (FGFs) provides a robust and generic
mechanism to support stem cell density regulation in the open
niche environment of the mouse testis.
RESULTS
FGF5 Expression in LE Cells Near the Vasculature and
Its Mitogenic Function on GFRa1+ Spermatogonia
As a starting point, we searched for key factors that could
contribute to GFRa1+ cell regulation. Based on the biased local-
ization of GFRa1+ cells toward the vasculature and the surround-
ing interstitium (Chiarini-Garcia et al., 2001; Hara et al., 2014;
Yoshida et al., 2007), we compared gene expression profiles be-
tween tubule regions facing the interstitium with areas facing
neighboring tubules (Hara et al., 2014; Figure 2A). These regions
were collected by laser capture microdissection and processed
for cDNA microarray analysis, providing 315 candidate genes
enriched in vasculature-associated regions (Table S1). A second
screening using in situ hybridization (ISH) revealed 11 genes that
showed similar expression in large flattened cells covering the
outer surface of the tubules near the interstitium (Figures 2B
andS1B). Among these, we focused on fibroblast growth factor 5
(Fgf5), because previous studies have emphasized the role
of FGF signals in providing mitogenic and anti-differentiation
effects on spermatogenic stem cells. This has been achieved
largely in vitro by adding FGF2 to culture media, although the
molecular identity of naturally acting FGFs in vivo remains elusive
(Kanatsu-Shinohara et al., 2003, 2014; Takashima et al., 2015).
FGF5+ flattened cells covered some 60% of the surface of the
tubules, with a significant bias toward areas facing the interstitium
(Figures S1C and S1D). Apart from a few interstitial cells, FGF5
was also immunolocalized to a subset of CD34+ LE cells in the
two layers of peritubular cells. LE cells, sometimes termed specif-
ically as parietal LE cells to avoid confusion with lymphatic vessel
endothelial cells, are so designated because they cover the sur-
face of lymphatic space (Clark, 1976; Kuroda et al., 2004; Figures
2C and S1E–S1G). Across the basement membrane and myoid
cells, GFRa1+ cells showed a significant positive spatial correla-
tion with FGF5+ LE cells, and NGN3+ cells and KIT+ cells showed
weaker and no correlations, respectively (Figures 2D, 2E, and
S1J; STARMethods). FGF5expressionwasobserved throughout
the seminiferous epithelial cycle (Figure S1I).
FGF5, like FGF2, promoted the proliferation of cultured
GFRa1+ spermatogonia in a concentration-dependent manner
(Figure 2F). FGF5 also led to the upregulation of genes associ-
ated with cell cycle progression (e.g., Ccnd2 and Myc), the
maintenance of an undifferentiated state (e.g., Etv5, Id4, Shisa6,
Gfra1, and Ret; Chan et al., 2014; Garbuzov et al., 2018; Meng
et al., 2000; Tokue et al., 2017; Tyagi et al., 2009), and the
downregulation of genes associated with differentiation (e.g.,
Ngn3,Miwi2,Sox3,Rarg, andStra8; Yoshida et al., 2004; Carrieri
et al., 2017; Raverot et al., 2005; Gely-Pernot et al., 2012; Ikami
et al., 2015; Endo et al., 2015), indicating the mitogenic and anti-
differentiation effects of the factor (Figure 2G). In vivo, GFRa1+
cells expressed FGF receptors as well as high levels of genes
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upregulated by FGF5 in vitro (Figure 2H), suggesting that
GFRa1+ cells receive the FGF5 signal. Further, in culture,
CD34+ cells prepared according to Seandel et al., 2007, which
indeed expressed Fgf5, supported the proliferation of GFRa1+
spermatogonia without additional FGF in the media (Figures 2I
and S1H). Together, these findings support the idea that FGF5,
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Figure 1. Testis Anatomy and Constant
Average Density of GFRa1+ Stem Cells
(A) Anatomy of a mouse testis and seminiferous
tubules.
(B) An image of a whole-mount seminiferous
tubule after immunofluorescence (IF), in which
positions of GFRa1+ cells are traced (magenta).
White and gray lines alongside the tubules indicate
1-mm-long segments, containing the indicated
numbers of GFRa1+ cells.
(C) Variable numbers of GFRa1+ cells contained in
a 1-mm-long segment (left) and the highly con-
stant average density over long continual seg-
ments over 10 mm (right). Horizontal lines indicate
the average values.
(D) Hierarchy (left) and interminglement (right;
a whole-mount IF of seminiferous tubules) of
GFRa1+, NGN3/RARg+, and KIT+ spermatogonia.
Scale bar, 100 mm.
produced by a subset of LE cells, contrib-
utes to the regulation of GFRa1+ cells
through mitogenic and anti-differentia-
tion roles.
FGFs Control GFRa1+ Cell Density
in a Linear Dosage-Dependent
Manner
We then investigated the role of FGF5 in
mice carrying a null allele (Fgf5) or an
extra copy of bacterial artificial chromo-
some-mediated transgene (BAC-Fgf5Tg)
(Khoa le et al., 2016; Mizuno et al., 2011)
(Figure S2A). In Fgf5–/– -mutant testes,
expression level of Gdnf did not change
(Figure S2B). Similarly, the number and
appearance of somatic cells, including
Sertoli cells, a crucial component for
stem cell regulation (Oatley et al., 2011),
did not change (Figures S2C–S2E). How-
ever, the average density of GFRa1+
spermatogonia showed a positive and
strikingly linear correlation with Fgf5
dosage (Figure 3A). We also observed a
decrease of testis weight, an increase of
abnormal tubules missing one or more
germ cell layers, and decrease of differ-
entiating germ cells in accordance with
the decreased Fgf5 dose (Figures
S3A–S3H).
During postnatal development, FGF5
expression was found to first accumulate
in CD34+ cells, which cover the entire tu-
bule surface, at around postnatal day 3 (P3), with levels
becoming stronger around P7 and then localized to the vascula-
ture-associated regions (Figure S3I). In parallel, GFRa1+ sper-
matogonia emerged postnatally by P3, both in WT and Fgf5mu-
tants. By P7, their density became already correlated with Fgf5
dosage (Figure 3B). Notably, during adulthood (up to 10 months
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of age), GFRa1+ cell density in mutants remained stable relative
toWT; loss or excess of Fgf5 caused no progressive depletion or
accumulation of GFRa1+ cells over time (Figures 3C and S3D).
Further, after an artificial reduction of the GFRa1+ cell pool by
busulfan treatment, within 3 months, their densities recovered
to their original levels specific to the respective genotypes (Fig-
ure 3D). We concluded that these mutants sustained steady-
state spermatogenesis with different density set points of
GFRa1+ cells that correlate in amanner that depends remarkably
linearly on Fgf5 dosage.
Because Fgf5/ homozygotes still maintain GFRa1+ cells,
we examined the involvement of other FGFs and detected
Fgf4 mRNA in a pattern similar to that of Fgf5 (Figures S4A
and S4C). We also detected FGF8 protein in rat LE cells
(Figures S4B and S4D). In common with Fgf5+/, both Fgf4+/
and Fgf8+/ heterozygotes showed a proportionate reduction
in GFRa1+ cell density, although homozygotes were embryonic
lethal (Figure 3E; Meyers et al., 1998; Sun et al., 2000). Remark-
ably, intercross between these mutants demonstrated that
GFRa1+ cell density also correlates linearly with the total dosage
of Fgf genes, regardless of the combinations (Figures 3E and
S4E–S4M). We concluded that multiple FGFs play key roles in
the regulation of GFRa1+ cell density. The observed dependence
of GFRa1+ cell density on total Fgf dosage indicates that FGF
signaling plays a limiting role in the regulation of spermatogenic
stem cell density.
Each GFRa1+ Cell Receives an Unchanged Level of FGF
Signal in Fgf5 Mutants
How does FGF signaling regulate quantitatively GFRa1+ cell
density? Given the mitogenic and differentiation-inhibiting func-
tions of FGF (Figures 2F and 2G), we first considered whether
GFRa1+ cells receive altered levels of FGF signal in mutants,
which in turn change their fate, resulting in altered densities. Sur-
prisingly, however, we found that the rates of proliferation, differ-
entiation (RARg+ to GFRa1+ cell ratio) and death of GFRa1+ cells
were not different between Fgf5/, BAC-Fgf5Tg/+, and WTmice
(Figures 3F–3H), indicating conserved fate behavior of GFRa1+
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Figure 2. Identification, Expression, and Mitogenic Function of FGF5
(A) Outline of the screening for genes preferentially expressed in the vasculature-associated region.
(B) Representative ISH images for Fgf5 (blue) in testis sections, counterstained with nuclear fast red. Asterisk, intertubular arterioles or venules.
(C) A representative IF image of a tubule periphery stained for FGF5 (green), CD34 (red), and aSMA (blue).
(D) Representative image of an intertubular region of a GFRa1-GFP mouse testis stained for GFP (green), FGF5 (magenta), and DNA (blue). Scale bars, 10 mm in
(B)–(D). Broken lines, outline of tubules (C and D).
(E) Relationship between Fgf5+ area and the position of spermatogonia. Detailed data are shown in Figure S1J.
(F) Mitogenic effect of FGF5 (red) or FGF2 (blue) on cultured spermatogonia. Fold increase in the number of germline stem (GS) cells cultured with indicated
concentration of FGF5 for 8 days. Shown in average ± SEM (n = 3 independent experiments).
(G) Effects of FGF5 on gene expression. GS cells depleted for FGF2 andGDNF for 3 days were supplemented with or without FGF5 (100 ng/mL) for 24 hr, followed
by cDNA microarray analyses.
(H) Gene expression of GFRa1+, NGN3+, and KIT+ cells in vivo, selected from our published cDNA microarray data of fluorescence-activated cell sorting
(FACS)-sorted spermatogonial fractions, normalized to the values from whole testis (Ikami et al., 2015).
(I) Amplification of GS cells co-cultured with mouse CD34+ testicular cells or mouse embryonic fibroblast (MEF) with or without FGF2.
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Figure 3. Dosage of Fgf Genes Quantitatively Determines the Density of GFRa1+ Cells
(A) Average densities ± SEM of GFRa1+ cells and representative IF images of whole-mount seminiferous tubules for GFRa1 of 2.5-month-old mice with indicated
genotypes. Scale bar, 50 mm. n, number of mice examined.
(B and C) Average densities ± SEM of GFRa1+ cells in mice with indicated genotypes during young (B) and adult (C) ages. **p < 0.05 compared to Fgf5+/+.
(D) Recovery of the GFRa1+ cell densities following busulfan treatment in adult mice with indicated genotypes. NS, not significant (t test).
(E) Relative average densities ± SEM of GFRa1+ cells in mice harboring the indicated dosages of functional Fgf5, Fgf8, and Fgf4 alleles. Results from Fgf5-Fgf8
(green), Fgf5-Fgf4 (orange), and Fgf5-Fgf4-Fgf8 (cyan) intercrosses were shown separately, given their different genetic backgrounds (Figures S5J and S5K).
(F–H) Indexes of proliferation (EdU+ and pH3+ fractions; F), differentiation (quantified as the RARg+/KIT [zNGN3+] over GFRa1+ cell ratio; G), and death (cPARP+
fraction; H) in GFRa1+ cells of indicated mice at 2.5 months of age.
(I) Global gene expression profiles in GFRa1+ cells of 2.5-month-old Fgf5+/+ and Fgf5/ mice, indicating some positive (red) and negative (blue) FGF5 targets
(Figure 2G). r, Pearson’s correlation coefficient.
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cells between mutants. Consistently, clonal fates of pulse-
labeled GFRa1+ cells were essentially unchanged in Fgf5/
mice compared to WT (Figure S4N; Hara et al., 2014). Further-
more, gene expression profiles of GFRa1+ cells were highly
conserved between Fgf5/ and WT, showing only minimal
differences in FGF target genes (Figures 3I and S4O). These
findings support the somewhat counterintuitive conclusion
that GFRa1+ cells receive largely unaltered levels of FGF signal,
even if the FGF dose and homeostatic GFRa1+ cell density
change.
This unexpected observation, as well as the linear relationship
between the Fgf dosage and GFRa1+ cell density, suggested
that the supply of FGF may be a limiting factor that is competed
for among the GFRa1+ cell population. In this case, the levels of
FGF signal received by each GFRa1+ cell would be equalized
among Fgf mutants harboring different GFRa1+ cell densities.
To develop this hypothesis, we then examined whether GFRa1+
cells consume the extracellular FGF when they receive its signal
in vivo, as this was probably the simplest form of competition
consistent with the general mechanism of FGF signal reception
by target cells (Ornitz and Itoh, 2015; Turner and Grose, 2010).
GFRa1+ Spermatogonia Consume FGF5
In general, efficient reception of FGF signal requires heparan sul-
fate (HS) proteoglycans (e.g., syndecans), whose HS chains bind
and transfer FGFs to the receptor tyrosine kinases (FGFRs) on
the target cells (Ornitz and Itoh, 2015; Turner and Grose, 2010).
Reception of FGF by these molecules is accompanied by inter-
nalization with the aid of syndecan binding proteins (SDCBPs),
transportation to multivesicular bodies, and degradation in lyso-
somes (Figure 4A; Goh and Sorkin, 2013; Hanson and Cashikar,
2012). Significant levels of mRNAs encoding these factors were
detected in GFRa1+ cells (Figures 2H and 4B). At the protein
level, FGFR2 and FGFR3 showed higher expression in GFRa1+
cells (Figures 4C, S5A, and S5B). Syndecan4 (SDC4) was de-
tected predominantly on the cell surface (Figure 4C) and in multi-
vesicular bodies (CD63+), which had been observed previously
by EM (Chiarini-Garcia and Russell, 2002; Figures 4E, S5C,
and S5D). GFRa1+ cells were also found to be rich in SDCBP
(Figures 4C and S5E). HS chains, especially those highly
sulfated, were also enriched in GFRa1+ cells, and HS was also
found over the basement membrane (Figure S5F). Thus,
GFRa1+ cells appeared to be well furnished with the reception
machinery for FGFs.
Moreover, we detected speckled FGF5 signals inside GFRa1+
cells (Figure 4D). Given the undetectable levels of Fgf5 tran-
scripts in these cells, these signals were most likely derived
from LE and interstitial cells (Figure 2B). Significant portions of
FGF5 cytoplasmic signals were co-localized with SDC4 as cyto-
plasmic puncta, on CD63+ multivesicular bodies, or on LAMP1+
lysosomes (Figures 4E and 4F). These observations indicated
that GFRa1+ cells consume extracellular FGF5, supporting the
idea that GFRa1+ cells compete for FGF. Interestingly, these fea-
tures were not restricted to GFRa1+ cells but were shared by the
entire population of undifferentiated spermatogonia, including
NGN3+ cells (Figures S5G and S5H). Together, these findings
indicate that the FGF signal is active in the interstitium-proximal
area, where GFRa1+ and NGN3+ undifferentiated spermato-
gonia may be the principal FGF target cells.
Homeostatic Stem Cell Density Regulation Follows from
a Model of ‘‘Mitogen Competition’’
To gain deeper insight into the mechanism of density regula-
tion, we developed a hypothesis based on the concentration-
dependent mitogenic and differentiation-inhibiting activity of
FGF, its supply from LE cells, and consumption by GFRa1+
cells (Figure 5A). To challenge this hypothesis, we developed
a minimal theoretical model (Methods S1), in which stem cells
(viz. GFRa1+ cells) are exposed to a steady supply of mitogens
(viz. FGF) from microenvironment (viz. LE cells), whose con-
sumption affects their fate behavior (viz. the probability to
self-renew or differentiate). For simplicity, we first focused on
the spatially averaged GFRa1+ cell density and mitogen con-
centration, returning later to consider the effect of spatial inho-
mogeneity of FGF production. The model is parameterized by
effective rate constants that reflect the timescales of (1) stem
cell proliferation and differentiation; (2) production, decay, and
consumption of mitogens; and (3) the sensitivity of cell fate
behavior to mitogen concentration (Figure 5A). Importantly,
these population-level rate constants are not equivalent to the
microscopic kinetic rate parameters; rather, they integrate the
net contribution of indirect effects on mitogen consumption
and processing, such as mitogen deposit to the basement
membrane, mitogen diffusion, spermatogonial movement, and
delays due to the successive activation of downstream targets
of the FGF receptor.
Analysis of the model dynamics showed robust convergence
to a homeostatic steady state, with a defined GFRa1+ cell den-
sity, independent of the starting condition, over a wide range of
rate parameters (Figure 5B; Methods S1). Qualitatively, when
the GFRa1+ cell density is low (cf. state ‘‘1’’ in Figure 5B), the
net rate of FGF consumption decreases, which in turn leads
to an increase of FGF concentration (cf. state ‘‘2’’). This drives
an increase in GFRa1+ cell density, as cells now tend to
proliferate rather than differentiate. When the GFRa1+ cell den-
sity becomes too large (‘‘3’’), the opposite situation prevails,
leading to a decrease of GFRa1+ cell density (‘‘4’’), which even-
tually converges to a homeostatic set point (green dot in Fig-
ure 5B). This scenario constitutes a negative feedback control
on GFRa1+ cell density, a requisite for robust homeostatic
regulation.
A key feature of this model is the emergence of a linear
correlation between the homeostatic GFRa1+ cell density and
FGF dosage (Figures 5C and 5D), as observed in Fgf mutants
(Figures 3C and 3E). Formally, this linear dependence is given
by s = ðm kc0Þ=k0 , where s is the homeostatic stem cell den-
sity, m is the FGF supply rate, k is its degradation rate, c0 is the
threshold concentration at which proliferation and differentia-
tion are balanced, and k
0
is the rate of FGF consumption by
stem cells. The model also captures the counterintuitive obser-
vation that the fate behavior of GFRa1+ cells does not change
in Fgf mutants (Figures 3F–3I and S4N), a consequence of the
steady-state FGF concentration being always pinned at the
level c0, at which the increase (renewal) and decrease (differen-
tiation) of GFRa1+ cells is balanced (Figures 5B and 5E;
Methods S1). Given that GFRa1+ cells effectively compete
with each other for the limited supply of FGFs (or mitogens
more generally), we refer to this mechanism as the ‘‘mitogen
competition model.’’
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Noting that NGN3+ cells may also consume FGFs (Figures
S5G and S5H), we questioned whether this might affect the pro-
posed mechanism. To this end, we extended our model to two
stem and progenitor cell compartments (Figures 5A0 and S6B),
which both compete for the same mitogen supply. Analysis
showed that the effect of the second (progenitor) compartment
is to effectively redefine the parameters of the one-component
model, although the main features are not affected (Methods
S1). Similarly, the key properties of the model do not rely on
the premise that all GFRa1+ cells harbor self-renewing potential
(Methods S1). Moreover, the phenomenology is not affected by
the potential for ‘‘reversion’’ between the progenitor and stem
cell compartments or by the inclusion of a stem cell death,
both of which occur in homeostasis, if infrequently (Hara et al.,
2014; Nakagawa et al., 2007, 2010; Figures S6C and S6D;
Methods S1). These findings emphasize the robustness of the
mitogen competition mechanism in ensuring tissue-level stem
cell homeostasis.
Figure 4. GFRa1+ Spermatogonia Uptake and Consume FGF5
(A) A general scheme of FGF reception on target cells, adopted from Hanson and Cashikar (2012). (Republished with permission of Annual Reviews, from
Multivesicular Body Morphogenesis, Phyllis I. Hanson and Anil Cashikar, volume 28, 2012; permission conveyed through Copyright Clearance Center, Inc.)
(B) Expression of genes indicated in GFRa1+, NGN3+, and KIT+ spermatogonial fractions, selected from published cDNAmicroarray data (Ikami et al., 2015), and
normalized to the values from the whole testis.
(C and D) Representative images of GFRa1+ or GFRa1-GFP+ (cyan) cells exhibiting the speckled cytoplasmic staining of FGFR2, SDC4, SDCBP (C), or FGF5 (D)
(magenta, white arrowheads) and cell surface SDC4 staining (white arrows). Cytoplasmic SDC4 signals often form prominent clusters (yellow arrowheads).
(E and F) Representative images of SDC4+ (magenta) cells co-stained for FGF5 (green) with CD63 (E) or LAMP1 (F; cyan). FGF5+ speckles (arrows) were often
co-localized with CD63+ (arrowheads) or LAMP1+ (arrowheads) foci in SDC4+ cytoplasmic clamp. Scale bars indicate 10 mm, and the broken lines show outlines
of the tubules in (C)–(F).
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The Mitogen Competition Model Explains the Dynamics
of Recovery from Injury and the Biased Spatial
Localization of Stem Cells
Having established the predictive capacity of the model under
homeostatic conditions, we then questioned whether the model
could predict quantitatively the dynamics of stem and progenitor
cells during regeneration following injection of the cytotoxic re-
agent, busulfan. Analysis of the model suggested that the recov-
ery of GFRa1+ cell density following a strong perturbation from
its steady-state (viz. uninjured) value should be accompanied
by decaying oscillations (Figures 5D and 5E). This oscillatory
behavior arises due to the ‘‘inert’’ feedback between stem cell
density and mitogen concentration (Figure 5B; Methods S1):
an abrupt stem cell depletion leads to decreased FGF consump-
tion, resulting in its accumulation; hence, stem cells now receive
large amounts of FGF, leading to a bias toward proliferation
beyond that experienced at homeostasis, resulting in an ‘‘over-
shoot’’ in stem cell density. This excess results in increased
FGF consumption, which now lowers the FGF concentration,
leading to a bias toward differentiation, pushing the density
below homeostatic levels, and causing the process to restart.
Indeed, the predicted density overshoot provides the means to
challenge the alternative hypothesis that stem cell pool size
might be determined as the maximum capacity of tissue.
To test this prediction, we examined the kinetics during recov-
ery after busulfan treatment in WT animals and, indeed, found
decaying oscillations of GFRa1+ cell density that converged to-
ward the steady-state value over several months (Figure 6A)
with a profile that matched quantitatively with theory (Figure 6B).
Using the corresponding parameter fit, the model further pre-
dicted an altered oscillation amplitude for decreased FGF supply
(Figure 6B), as well as the phase shift of oscillations of the
NGN3+/RARg+ cell density (Figure 6C), supporting the integrity
of the mitogen competition model.
Finally, we questioned whether the mechanism of mitogen
competition could further explain the biased localization of
GFRa1+ (and, to a lesser extent, NGN3+) cells to FGF sources
(Figures 2D and 2E). Indeed, an extension of the model account-
ing for a spatial distribution of FGF sources and spermatogonial
motility (Hara et al., 2014) could predict the emergence of such a
bias while preserving the global characteristics of the popula-
tion-level models (Figures S6F–S6H; Methods S1). Within the
framework of themodel, localization of GFRa1+ cells to the vicin-
ity of FGF sources arises solely from their acquired bias toward
A
A’
B
D E
C
Figure 5. The Mitogen Competition Model
(A and A0) Feedback diagrams of the ‘‘mitogen competition’’ model, showing the mutual regulation of the stem cell density and FGF abundance; (A) case in which
only stem cells (‘‘S’’) consume FGF; (A0) case in which, in addition, the differentiation-destined progenitors (‘‘D’’) also consume FGF.
(B) Phase portrait showing the dynamics of stem cell density and FGF concentration in the mitogen competition model. The system possesses two fixed points: a
homeostatic state (green dot) and a loss state (red dot). For the shown parameter set, only the homeostatic state is stable, as all trajectories obtained by following
the arrows converge toward this state (e.g., the trajectory indicated by numbered dots). Here, c0 is the threshold FGF concentration at which duplication and loss
by differentiation exactly balance; the steady state is set at a stem cell density s = ðm kc0Þ=k 0 and c = c0 (parameters explained in themain text). Blue dots (1–4)
are provided to explain qualitatively the model dynamics (see main text). Parameters are given in Table S2.
(C) Steady-state stem cell density as a function of the FGF supply rate. Above the critical supply rate, the homeostatic state is stable (shaded area) and the
homeostatic stem cell density depends linearly on the FGF supply rate. Below a critical supply rate, the loss state is stable (white area) and stem cell loss is
inevitable. Parameters are as in (B).
(D and E) Numerical examples of the model simulation showing the GFRa1+ cell density (D) and tissue FGF concentration (E), starting from arbitrary initial
conditions. Red, yellow, blue, and purple lines indicate different rates of FGF production (m=c0 = 0:15; 0:2; 0:25; 0:3d
1 in this order). All other parameters are given
in Table S2.
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stem cell proliferation, whereas those more remote have a
greater tendency to become lost through differentiation. In this
regard, the mitogen competition model suggests a key role for
migratory activity in combination with dynamic cell fate biases
in promoting localization, and chemo-attraction may not be
requisite to explain spatial biases.
Finally, to challenge the predicted causal relationship between
the local FGF concentration and GFRa1+ cell density, we per-
turbed the distribution of FGF by implantation of FGF5-soaked
beads alongside the seminiferous tubules for 5 days, as
Figure 6. Impact of Temporal and Spatial
Perturbations from Homeostasis
(A) Observed kinetics of the GFRa1+ cell density
following busulfan treatment in WT (left) and ex-
amples of IF images of whole-mount seminiferous
tubules stained for GFRa1 (right) at the segments
indicated by red circles in Figure S5I.
(B) Model results (curves) compared to experi-
mental measurements (dots) of the average
GFRa1+ cell density following busulfan treatment
in WT (dark blue, model fit) and Fgf5/ (light blue,
model prediction) mice. Experimental data are
rescaled from (A).
(C) Model prediction (magenta curve) and experi-
mental measurement (dots) of the average
density of NGN3+ (in particular, RARg+/KIT) cells
following busulfan treatment in WT. The GFRa1+
cell density is reproduced from (B) for comparison
(blue curve). Throughout, average densities ± SEM
ofR4 testes at each data point are shown.
(D) In vivo transplantation of DiI-labeled/
FGF5-soaked beads into testicular interstitium.
DiI transfers to the proximal region of the host
seminiferous tubules.
(E) A whole-mount image of a part of host semi-
niferous tubules showing theGFRa1 (white) and DiI
(magenta) signals.
(E’) Trace of GFRa1+; cells in the top (E) and bottom
surfaces were projected, with enhanced DiI signal
overlain (red).
(F and G) Magnified images of the areas indicated
in (E), representing DiI-positive (F) and negative (G)
regions.
(H and I) Representative images of DiI-positive
(H) and negative (I) regions after transplantation of
BSA-soaked beads.
(J) GFRa1+ cell densities (numbers contained
in 1-mm-long segment) in DiI-positive and nega-
tive areas after transplantation of FGF5- or BSA-
soaked beads. **p < 0.05 compared to DiI-positive
areas after transplantation of FGF5-soaked beads
(t test).
Scale bars, 50 mm.
described previously (Figure 6D; Uchida
et al., 2016). Untangled tubules were
then immunostained to define the position
of GFRa1+ cells in relation to that of the
beads marked by DiI. These results
showed that the GFRa1+ cell density
was locally increased in areas proximate
to FGF5-soaked beads, but not BSA-
soaked beads, supporting the conclusion
that FGFs locally regulate GFRa1+ cell density (Figures 6E–
6J). The increased density of GFRa1+ cells in areas adjacent
to the beads paralleled an increased EdU uptake (Figures
S6M and S6N). Over longer time courses, the GFRa1+ cell
density decreased, followed by an increase of GFRa1 undiffer-
entiated spermatogonia, a trend captured by theory (Fig-
ure S6M). Indeed, this increase may explain recent reports
that, perhaps counterintuitively, associate FGF2 with the upre-
gulation of RARg and the promotion of differentiation (Masaki
et al., 2018).
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DISCUSSION
In this study, we have targeted themechanism of spermatogenic
stem cell density homeostasis in the open, or facultative, niche
environment of the basal compartment of seminiferous tubules.
Our results show that the in vivo fate behavior of GFRa1+ cells is
regulated by the mitogenic and anti-differentiation effects of
FGFs (FGF5, 8, 4, and possibly others) released from a subset
of LE, and interstitial, cells that lie in proximity to the vasculature
(Figure 7A). We propose competition for mitogens as a mecha-
nism that can explain the regulation of stem cell pool size, as
well as their bias toward the mitogen source. In this framework,
FGFs play a key role as fate determinants for which stem cells
compete (Figure 7B). Cells receiving more FGF become biased
toward proliferation over differentiation, most likely through
elevated expression of cell-cycle-promoting and differentia-
tion-inhibiting genes, as well as decreased expression of differ-
entiation genes. In contrast, cells receiving less FGF become
primed toward differentiation with opposite patterns of FGF
target gene expression. We found that a minimal model of
mitogen competition could account quantitatively for a variety
of key properties, including the dependence of the homeostatic
stem cell density on mitogen supply and the oscillatory recovery
toward steady state after drug-induced perturbation. Together,
these findings suggest that feedback through mitogen con-
sumption plays a major role in density regulation of spermato-
genic stem cells, although additional mechanisms of competi-
tion cannot be ruled out.
Themitogen competitionmechanism does not rely on whether
the stem cell compartment is ‘‘hierarchical’’ or whether it re-
ceives influx from a differentiating progenitor compartment via
‘‘reversion’’ or ‘‘dedifferentiation’’ (Figures S6C and S6D; Helsel
et al., 2017; Yoshida, 2018b). In this context, we found that Id4, a
proposed stem cell marker (Chan et al., 2014), was widely ex-
pressed across and even beyond the GFRa1+ cell population
both at mRNA and protein levels (Figures S7A–S7C), consistent
with La et al. (2018), although Id4+/high cells were found to be
spatially correlated with FGF5+ LE cells and the interstitium (Fig-
ures S7D and S7E; Yoshida, 2018a).
This study identifies FGF-producing LE cells as a key regulator
of spermatogenic stem cells, which work in concert with other
cells, such as Sertoli cells, myoid cells, Leydig cells, and macro-
phages (Chen et al., 2016; DeFalco et al., 2015; Oatley et al.,
2011). It is notable that LE cells express FGF5 at uniform levels
over the seminiferous epithelial cycle (Figure S1I). This contrasts
GDNF, WNT, and RA signals, which show temporal oscillation in
synchrony with the seminiferous cycle-related (and spatially ho-
mogeneous) gene expression of Sertoli cells (Grasso et al., 2012;
Ikami et al., 2015; Sato et al., 2011; Sharma and Braun, 2018; To-
kueetal., 2017; Vernet et al., 2006).Echoing this, our screeningdid
not identify genes showing vasculature-related expression in Ser-
toli cells, suggestinga separationof temporal andspatial control of
stem cells between Sertoli cells and FGF-producing LE cells,
respectively. In future studies, it will be important to understand
whether, in addition to FGFs, other signaling molecules (such as
GDNF) participate directly in stem cell regulation through the
samemechanismofmitogencompetition and, if theydo, how their
function is integrated spatio-temporally with that of FGFs.
In addition to FGF5, 8, and 4, expression of FGF2 has been
reported in the testis, although it was not detected in our ISH
(Mullaney and Skinner, 1992; Smith et al., 1989). Given the unde-
tectable mRNA level (Figures S4P and S4Q) and the reported
nuclear localization of the protein in undifferentiated spermato-
gonia (Gonzalez-Herrera et al., 2006), GFRa1+ cells may also
uptake exogenously supplied FGF2, whichmay play similar roles
in stem cell regulation to the aforementioned FGF members.
Figure 7. Proposed Stem Cell Regula-
tion in Seminiferous Tubules by Mitogen
Competition
(A) A schematic of the microenvironment regu-
lating GFRa1+ spermatogonia. In the basal
compartment of seminiferous tubules, FGFs are
produced and secreted by a subset of LE cells and
a few interstitial cells. FGFs, which have an affinity
to the basement membrane, are taken up and
consumed by motile GFRa1+ spermatogonia and
biases their fate behavior in a concentration-
dependent manner (see B). This leads to higher
local densities of GFRa1+ cells near the FGF
source (near the interstitium accompanying
arterioles or venules) compared to those distant
from the source.
(B) In the basal compartment, GFRa1+ cells
effectively compete for a limited supply of FGF.
Cells receiving larger amounts of FGF will show
higher expression of cell-cycle-promoting and
anti-differentiation genes and lower expression of
differentiation-promoting genes, tilting their fate
toward proliferation without differentiation. Cells
receiving smaller amounts of FGF will show
opposite patterns of target genes, tilting their fate
toward differentiation.
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Based on these findings, it is instructive to contrast the mech-
anistic basis of stem cell regulation in systems reliant on an open,
or facultative, niche versus those involving a closed, or definitive,
niche. In definitive niche-supported tissues, stem cells are gath-
ered to a restricted region where mitogens are concentrated so
that physical access determines stem cell pool size (Kitadate
et al., 2007; Spradling et al., 2011). In contrast, in the open
environment of the seminiferous tubules, stem cells are not
tightly linked spatially with the source of mitogen (FGFs) but
are dispersed among their differentiating progeny. Our results
show that competition for mitogens, released by somatic niche
cells, allows stem cells to ‘‘sense’’ their local density and adjust
their fate bias in response, which provides amechanistic basis to
understand the dynamics of population asymmetry (Hara et al.,
2014; Klein et al., 2010; Nakagawa et al., 2007).
A key element characterizing niche types is the effective
range of niche-derived factors (Inaba et al., 2015). Indeed, in
Drosophila testes and ovaries, diffusion of niche factors (e.g.,
bone morphogenetic protein [BMP]) is limited through their
binding to heparansulfate proteoglycans (HSPGs) so that it
only affects the cells next to the hub (Chen et al., 2011; Nakato
and Li, 2016). In the open niche environment of mouse testis,
diffusion alone may not explain the long-range effect of FGFs,
because free ligands are likely diluted out quickly from the
basal compartment by the systemic extravascular circulation.
Rather, given the affinity with HSPGs, FGFs are expected to
be immobilized (and concentrated) on the HS-rich basement
membrane (Figure S5F). However, by harboring abundant
HSPGs (e.g., Sdc4) and highly sulfated HS, GFRa1+ and
NGN3+ spermatogonia should have a high affinity for FGFs
(Figures 4C, S5D, S5F, and S5H). By up-taking FGFs from
the basement membrane, the motility of spermatogonia pro-
vides a mechanism to enhance the effective range of FGFs
into areas distant from the FGF source. Indeed, such ‘‘passen-
ger diffusion’’ associated with the stem cell motility may under-
lie the long-range effect of niche factors in other open niche-
supported systems.
In summary, we have shown how mitogen competition pro-
vides a basis to regulate stem cell density regulation in an
open niche environment. Such behavior constitutes a novel
form of ‘‘quorum sensing,’’ reminiscent of that exploited by
bacterial populations (Miller and Bassler, 2001) and ecological
systems, as it enables cells to respond to changes in the local
density of neighbors through the amount of secreted factors.
However, in contrast to mechanisms reliant on competition
for nutrients, which lead to starvation of excess populations,
here, it is the ‘‘priming’’ for different fate outcomes (viz. duplica-
tion versus differentiation) that leads to an effective population
size control. Hence, rather than playing the role of a finite
energy supply, the resource that is competed for (the mitogen)
exerts a fate control. Homeostasis through mitogen competi-
tion also shares similarities with the mutual proliferative regula-
tion of different cell types by secreted growth factors, as
recently reported for fibroblasts and macrophages (Adler
et al., 2018; Zhou et al., 2018); however, in the seminiferous tu-
bules, the LE cells provide a constant supply of the signaling
environment for stem cells, enabling them to restore and main-
tain homeostasis, even when perturbed strongly from steady
state by crisis or injury.
Finally, basedon these findings, it is useful to reflect onwhether
mitogen competition may be involved in themechanism of tissue
stem cell regulation in other contexts. In the canonical ‘‘definitive
niche’’ environment of the Drosophila testis, physical contact of
germline stem cells to a cluster of somatic hub cells provides
both local cues that orient cell division perpendicular to the hub
and access to signaling factors that maintain stem cell compe-
tence; together, these influences promote the asymmetric fate
of mitotic sisters based on their proximity to the hub (Spradling
et al., 2011). However, live-imaging assays show that a fraction
of sister pairs undergo symmetric differentiation or symmetric
self-renewal in a locally coordinated manner so that, through a
local repositioning on thehub, thenumber of stemcells thatmain-
tain access to niche-supporting signals remains constant (Sheng
and Matunis, 2011). Such stem cell renewal mechanisms may
represent an extreme limit of the mitogen competition paradigm,
where the extent of ‘‘mitogen’’ localization and degree of stem
cell motility are limited. From this perspective, the functional
behavior of the open (facultative) and closed (definitive) niche
might not be altogether distinct. Rather, they may represent the
twoextremesof a continuum, inwhich themechanismofmitogen
competition provides a unifying framework. Whether the mecha-
nism of mitogen competition can indeed serve as a basis to
explain stem cell pool regulation in a wide variety of niche envi-
ronments warrants future in-depth investigation.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Goat polyclonal anti-GFRa1 (used at 1:1000) R&D Cat#AF560, RRID: AB_2110307, Lot 0411081
Goat polyclonal anti-FGF5 (used at 1:1000) Santa Cruz Cat#sc-1363, RRID: AB_2102680, Lot C1810
Rat monoclonal anti-CD34 (RAM34) (used at 1:200) eBioscience Cat#14-0341-82, RRID: AB_467210, Lot E019241
Mouse monoclonal anti-aSMA (1A4) (used at 1:200) Sigma-Aldrich Cat#A5228, RRID: AB_262054, Lot 128K4843
Rabbit polyclonal anti-GFP (used at 1:400) Thermo Fisher Cat#A-11122, RRID: AB_221569, Lot 1828014
Rat monoclonal anti-GFP (used at 1:300) Nacalai Tesque Cat# 04404-84, RRID: AB_10013361
Rabbit monoclonal anti-RARg (used at 1:200) Cell Signaling Technology Cat#8965, Lot 1
Goat polyclonal anti-c-Kit (used at 1:400) R&D Cat#AF1356, RRID: AB_354750
Rat monoclonal anti-c-Kit (used at 1:200) BD Cat#553355, RRID: AB_394806
Rabbit polyclonal anti-SOX9 (H-90) (used at 1:200) Santa Cruz Cat#sc-20095, RRID: AB_661282, Lot E1412
Rabbit polyclonal anti-CSF1R (used at 1:200) abcam Cat#ab183316
Rabbit monoclonal anti-StAR (used at 1:200) Cell Signaling Technology Cat#8449, RRID: AB_10889737, Lot 1
Rabbit polyclonal anti-phospho-Histone H3 (Ser10) (used
at 1:300)
Millipore Cat#06-570, RRID: AB_310177, Lot 2664259
Rabbit polyclonal anti-Cleaved PARP (D214) (used
at 1:200)
Cell Signaling Technology Cat#9544, RRID: AB_2160724, Lot 4
Mouse monoclonal anti-FGF8 (used at 1:1000) Kyowa Hakko Kirin Cat#KM1334, Lot KM1334-2
Rabbit polyclonal anit-FGFR2 (used at 1:200) abcam Cat#ab10648, RRID: AB_297369, Lot GR19748-1
Rabbit polyclonal anti-SDC4 (Syndecan4) (used at 1:2000) abcam Cat#ab24511, RRID: AB_448112, Lot GR5827-3
Rabbit polyclonal anti-SDCBP (Syntenin) (used at 1:2000) abcam Cat#ab19903, RRID: AB_445200, Lot GR592112-1
Rat monoclonal anti-CD63 (NVG-2) (used at 1:200) BD Cat#564221, Lot 4076990
Rat monoclonal anti-LAMP1 (1D4B) (used at 1:200) Santa Cruz Cat#sc-19992, RRID: AB_2134495, Lot L2313
Rabbit polyclonal anit-FGFR3 (used at 1:200) abcam Cat#ab10651, RRID: AB_297372, Lot 888076
Rabbit monoclonal anit-Id4 (used at 1:2000) Cal Bioreagents Cat#M106, RRID: AB_1151797
Rat monoclonal anti-ECAD (used at 1:2000) TaKaRa Cat#M108
Rat monoclonal anti-CD9 conjugated by Alexa Fluor 647
(used at 1:2000)
Biolegend Cat#124809, RRID: AB_1279319
Rat monoclonal anti-c-Kit conjugated by PE/Cy7 (used
at 1:2000)
Biolegend Cat#135111, RRID: AB_2131136
Rat monoclonal anti-ECAD conjugated by PE (used
at 1:2000)
This study N/A
Mouse monoclonal anti-NAH46 conjugated by Alexa
Fluor 647
This study N/A
Mouse monoclonal anti-HepSS1 conjugated by Alexa
Fluor 488
This study N/A
Chemicals, Peptides, and Recombinant Proteins
Recombinant Human FGF-5 R&D Cat#237-F5, Lot GQ2312021
Recombinant Human FGF-basic PeproTech Cat#100-18B, Lot 121008
Bovine albumin MP Biomedicals Cat#810661
Fluoro-KEEPER Antifade Reagent Nacalai tesque Cat#12593-64
Hoechst33342 Thermo Fisher Cat#H3570, Lot 23363W
Bouin’s solution MUTO PURE CHEMICALS Cat#3314-2, Lot 170228
Schiff reagent Wako Cat#193-08445, Lot LKP7191
Hematoxylin MUTO PURE CHEMICALS Cat#2104-2, Lot 160107
Eosin Wako Cat#051-06495, Lot LKQ2516
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Shosei
Yoshida (shosei@nibb.ac.jp).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
The following mice were as previously described: Fgf5– (Fgf5go-moja/Utr), BAC-Fgf5, Fgf4flox, Fgf8–, Ngn3-Cre, Gfra1-GFP, and
Ngn3-GFP. The background of Fgf5–, Gfra1-GFP, Ngn3-GFP, BAC-Fgf5, and the control wild-type mice was C57BL/6 (Japan
SLC, Japan CLEA), while Fgf8– mice was maintained in a CD-1 background. Fgf4 and Fgf8mutants were obtained from the Mutant
Mouse Regional Resource Centers. Intercross between Fgf5 and Fgf4 or Fgf8mutants were done following the mating scheme (Fig-
ures S5J and S5K). Busulfan (10 mg/kg) was intraperitoneally injected to adult mice (2.5–4 months old) as described previously. All
animal experiments were conducted with the approval of The Institutional Animal Care and Use Committee of National Institutes of
Natural Sciences, or institutional committees for animal and recombinant DNA experiments at the Research Institute, Osaka
Women’s and Children’s Hospital.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Vybrant CM-DiI cell-labeling solution Thermo Fisher Cat#V-22888
Affi-Gel Blue Media BIO-RAD Cat#153-7302, Lot 64035867
Laminin, mouse BD Cat#354232, Lot A1741
Critical Commercial Assays
Click-iT EdU Alexa Fluor 594 or 647 Imaging Kit Thermo Fisher Cat#C10339 or C10640
HistoGene LCM Frozen Section Staining Kit Thermo Fisher Cat#KIT0401
RNeasy micro kit QIAGEN Cat#74004
DIG RNA Labeling Kit Roche Cat#1175025
Superscript III first strand synthesis system Thermo Fisher Cat#18080051
THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#QPS-201
RNAscope Fluorescent Multiplex Detection Reagents Advanced Cell Diagnostics REF 320851, Lot 15127A
Lipofectamine 3000 Transfection Reagent Thermo Fisher Cat#L3000-015
Dual-Luciferase Reporter Assay System Promega Cat#E1960, Lot 0000144524
Deposited Data
Microarray data This study GEO: GSE118846
Experimental Models: Organisms/Strains
Mouse: Fgf5– (Fgf5go-moja/Utr):C57BL6J (Mizuno et al., 2011) N/A
Mouse: BAC-Fgf5:C57BL6J (Khoa le et al., 2016) N/A
Mouse: Fgf4flox (Sun et al., 2000) N/A
Mouse: Fgf8–:CD-1 (Meyers et al., 1998) N/A
Mouse: Ngn3-Cre:C57BL6J (Yoshida et al., 2004) N/A
Mouse: Gfra1-GFP:C57BL6J (Uesaka et al., 2007) N/A
Mouse: Gfra1-CreERT2:C57BL6J (Uesaka et al., 2007) N/A
Mouse: CAG-CAT-GFP:C57BL6J (Kawamoto et al., 2000) N/A
Mouse: Ngn3-GFP:C57BL6J (Yoshida et al., 2004) N/A
Oligonucleotides
Primers for qRT-PCR, Table S3 N/A
Probe-Mm-Fgf5 Advanced Cell Diagnostics P/N 417091, L/N 14070A
Probe-Mm-CD34-C2 Advanced Cell Diagnostics P/N 319161-C2, L/N 14062A
Probe-Mm-Des-C3 Advanced Cell Diagnostics P/N 407921-C3, L/N 14070A
Recombinant DNA
FANTOM clones, Table S1 DNAFORM N/A
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METHOD DETAILS
Immunofluorescence (IF)
Whole-mount IF of seminiferous tubules and IF on testis cryosections (10mm-thick) were performed as previously described (Hara
et al., 2014; Nakagawa et al., 2010; Tokue et al., 2017). The following antibodies were used: anti-GFRa1, anti-FGF5, anti-CD34,
anti-aSMA, anti-GFP, anti-RARg, anti-c-Kit, anti-SOX9, anti-CSF1R, anti-StAR, anti-pH3, anti-Cleaved PARP, anti-FGF8, anit-
FGFR2, anti-SDC4, anti-SDCBP, anti-CD63, anti-LAMP1, anti-FGFR3, anti-ID4. All secondary antibodies were Alexa Fluor conju-
gated from Life Technologies and used at 1:300 dilutions. Anti-NAH46 and anti-HepSS-1 antibodies (Seikagaku) were directly
labeled with Alexa Fluor 488 5-SDP ester (Molecular Probes, A30052) and Alexa Fluor 647 NHS ester (Molecular Probes,
A20006), respectively, as follows. Conjugation reaction was performed by mixing antibody solution (1.0 mg/ml in PBS) and 1/50 vol-
ume of the reactive dye (10 mg/ml) and incubating for 1.5 h at room temperature under dark conditions. Unconjugated dye was
removed by gel filtration using Bio-Spin 6 Tris Columns (#732-6227; Bio-Rad) to collect the labeled antibody as a flow-through
fraction. The nuclei were stained with hoechst33342 (Life Technologies). Slides were mounted in Fluoro-KEEPER Antifade Reagent
(Nacalai). Observations andmeasurements were performed using anOlympus BX51 upright fluorescencemicroscope equippedwith
a DP72 CCD camera, a Nikon A1r confocal system, or a Leica TCS SP8 confocal system.
Clonal fate analysis of GFRa1+ cells
Fgf5+/+ or Fgf5–/–; GFRa1-CreERT2; CAG-CAT-GFP mice were injected intraperitoneally with 0.25 mg of 4-hydroxytamoxifen per
individual (sigma). After the tamoxifen treatment, the testes were removed and analyzed by IF, as described previously (Hara
et al., 2014).
Bead preparation and transplantation
Affi-Gel blue beads (Bio-Rad) were soaked in a solution of recombinant FGF5 proteins (0.1 mg/ml) or 0.1% BSA (bovine serum
albumin; 0.1 mg/ml) for 1 h at room temperature according to (Uchida et al., 2016). To mark the tubular wall adjacent to the trans-
planted beads, some beads were immersed in DiI (0.83 mg/ml; Thermo Fisher Scientific) solution for 15 min. For transplantation,
the soaked beads were transplanted into the testicular interstitium (1 or 2 beads [one per site] were separated with appropriate
intervals) via vitrified micro-capillary under a dissecting microscope.
Laser capture microdissection
Freshly isolated testes from 8 weeks-old C57BL/6 mice were cryosectioned with 7mm-thick sections, placed on slides, fixed, and
stained with HistoGene before collection of the areas of interest using PixCell IIe (ArcturusXT), according to the manufactures’ pro-
tocol. The obtained tissue fragments were proceeded for cDNA microarray gene expression analysis.
cDNA microarray gene expression analysis
From tissue fragments collected by laser microdissection, RNA was purified using RNeasy micro kit (QIAGEN) and processed for
two-round amplification to prepare fluorescence-labeled probes as described. Briefly, in the first round, RNA samples were
reverse-transcribed with T7-(dT)24 primer and made double-stranded, followed by cRNA synthesis using MEGAscript T7 kit
(Ambion). After quality checked with an Agilent 2100 Bioanalyzer, cRNA was reverse-transcribed into ds-cDNA, and subjected to
Cy3-labeled cRNA synthesis (Agilent Technology) by T7 reaction. From other materials (i.e., tissues, sorted cells, or cultured cells),
RNA purification and preparation of Cy3-labeled cRNA probes were performed as described. Hybridization, scanning and data
analysis were done as described. Briefly, Cy3-labeled probes were fragmented and hybridized to an Agilent whole mouse genome
4x44K or 8X60K array (Agilent Technology). Then, the image data was obtained using a G2505C scanner (Agilent Technology),
analyzed using a Gene Spring software (Silicon Genetics). Data correction was performed with the threshold raw signals set to
1.0, percent shift to the 75th percentile as normalization algorithm, and no baseline transformation.
in situ hybridization (ISH) of histological sections
315genes that showedhighenrichments to vasculature-associated regionsover tubule-bounding regionswere selectedbasedon the
microarray data above. dsDNA fragments containing full length sequences of these transcripts were amplified from FANTOM clones
(DNAFORM) using the primers of M13_Forward: CGACGTTGTAAAACGACGGCCAGTG and M13_Reverse: AGCGGATAACAATTT
CACACAGGAAAC. Then, digoxigenin-labeled antisense RNA probes were synthesized using DIG RNA Labeling Kit (Roche) and pro-
cessed for in situ hybridization on paraffin embedded sections, according to a protocol described previously (Yoshida et al., 2001).
ISH of dispersed testicular cells
ISH of dispersed single cells was carried out using an RNAscope Fluorescent Multiplex Kit (Advanced Cell Diagnostics). Freshly iso-
lated testis from 8 weeks-old C57BL/6 mice were processed to generate cell suspensions of the interstitial cells and the peritubular
cells on the seminiferous tubules by pipetting. The cell suspension was applied to MAS-GP-coated slide glass (Matsunami) and
employed for detection of Fgf5, Cd34 and Des RNA using each specific target probe and HybEZ Hybridization system (Advanced
Cell Diagnostics).
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RT-qPCR
Total RNA was extracted form samples (tissues, sorted cell or cultured cells) using RNeasy kits (QIAGEN), reverse-transcribed using
Superscript III first strand synthesis kit (Life Technologies), and processed for RT-qPCR using a LightCycler 480 system (Roche) with
gene-specific primers (Table S3).
FACS
For microarray analysis, GFRa1+, NGN3+ and KIT+ cell fractions were sorted by FACS, as described previously (Ikami et al., 2015;
Tokue et al., 2017). The GFRa1+ fraction was collected fromGfra1-GFPmice as the GFP+ fraction, and the NGN3+ and KIT+ fractions
were collected from Ngn3-GFP mice as GFP+/KIT– and GFP+/KIT+ fractions, respectively, using an EPICS ALTRA instrument
(Beckman Coulter). The data of FACS and the microarray were partly published previously (Ikami et al., 2015; Tokue et al., 2017),
with the data-set deposited in the GEO (GSE75532). In Figure 3I, GFRa1+ cells were collected from 2.5 months-old-adult Gfra1-
GFPmice in wild-type and Fgf5–/– backgrounds in the samemanner to (Ikami et al., 2015; Tokue et al., 2017). In Figure S7, spermato-
gonial fractions were sorted from Gfra1-GFPmouse testicular cell suspension, based on CD9, ECAD, KIT and GFP staining, using a
FACSAria II cell sorter (BDBiosciences). Anti-ECAD antibodies were conjugatedwith PE by R-Phycoerythrin AffiniPure Fab Fragment
Goat Anti-Rat IgG (Jackson ImmunoResearch).
In vitro culture of spermatogonia
Germline Stem (GS) cells derived from the C57BL/6 x ICR intercrossed mice were maintained according to (Tokue et al., 2017). For
the quantification of mitogenic effect of FGF2 or FGF5, 23 104 GS cells per well of 12-well plate were cultured in the respective con-
centration of FGF2 or FGF5 in supplement with 10 ng/ml GDNF. After 8 days, the cell numbers were counted (n = 3 independent ex-
periments). For the gene expression analysis, GS cells were depleted for FGF2 and GDNF for 3 days, and then supplemented with or
without FGF5 (100 ng/ml) for 24 hours, followed by cDNA microarray analyses. For the co-culture with CD34+ cells or MEF, GS cells
were cultured in supplement with GDNF, and with or without FGF2. The passage was performed every 6 days.
Culture of CD34+ cells
Primary testicular cells expressing CD34 were prepared from 8 wk-old mice referring to (Seandel et al., 2007), which designated
these cells as mouse testicular stromal, or MTS, cells. Seminiferous tubules were collected from detunicated testes and minced.
The tissue was washed and then enzymatically dissociated with agitation at 37 C in a buffer containing collagenase, hyaluronidase,
andDNase I. The resultant cell suspension (non-filtered) was collected, plated in dishes coatedwith gelatin in a 50:50mixture of alpha
MEM/StemPro-34 (Thermo Fisher Scientific) supplemented with 20% FBS and expanded over two to five passages. Cells were then
cryopreserved or plated in 12-well plates coated with gelatin, and treated with mitomycin-C for 3 h, before use for co-culture with
GS cells.
Luciferase assay
Transient transfection of GS cells cultured in 48-well plates coated with laminin (BD Biosciences) was performed using Lipofect-
amine-3000 (Thermo Fisher Scientific), and the culture medium was changed after 24h. Analyses were performed 24h post-medium
change with or without FGF2. The luciferase activity of cell lysates was measured using a Dual-Luciferase assay system and a
GloMax 20/20n luminometer (Promega). The activity of the firefly luciferase reporter pGL4-Ngn3 was normalized to that of Renilla
luciferase expressed from co-transfected pGL4.7 plasmid as described (Tokue et al., 2017).
Copy number determination of the BAC transgene
Genomic DNA was extracted from tail clips of WT and mutant mice according to a standard protocol, including phenol-chloroform
extraction after lysis in buffers containing Proteinase K. To quantify the BAC transgene including the Fgf5 gene (Figure S2A), the real
time TaqMan PCRmethod using universal Probe Library probes (Roche) and gene-specific primers was used (Table S3). Copy num-
ber of Fgf5 was determined using Ppia as a standard.
QUANTIFICATION AND STATISTICAL ANALYSIS
Histology, evaluation of degenerating tubules, and measurement of the tubule area
Testes of WT andmutant mice were fixed with Bouin’s fixative and processed for paraffin-embedded section preparation (7mm thick)
and hematoxylin and eosin staining, according to standard procedures. The percentage of degenerating seminiferous tubules was
calculated based on the cross sections of seminiferous tubules (n > 200) that appeared on one transverse section for each testis. In
normal (WT) mouse testes, four generations of germ cells, each synchronously progressing through spermatogenesis, form cellular
associations of fixed composition (called seminiferous epithelial stages). Chronological sequence of these stages represents the
periodic change of seminiferous epithelium, known as ‘‘seminiferous epithelium cycle.’’ In the testes of Fgf mutants, a few tubule
cross-sections lacked one or more out of the four germ cell layers, which was defined as ‘‘degenerative tubules’’ in this study.
The area of the cross sections of seminiferous tubules were measured (n = 255 and 195 tubule sections in WT and Fgf5–/– mice,
respectively). The round shape tubule cross sections were photographed under bright-field illumination, then measured the areas
by a CellSens Standard software of an Olympus BX51 microscope.
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Counting the density of GFRa1+ or RARg+ cells
The densities of GFRa1+ or RARg+ cells were measured on immunofluorescenced whole mount seminiferous tubules or cryo-sec-
tions of the testes. Figures 1C, 3A, right, 6A, 6B, 6J, S2E, S6M, and S6N were counted by the whole mount seminiferous tubules. For
counting the cell density in 1 mm tubule length, the 1mm tubule length was measured, then the GFRa1+ cell number was counted by
an Olympus BX51 fluorescence microscope equipped with a DP72 CCD camera or a Leica TCS SP8 confocal system. For counting
the GFRa1+ cell density in > 10 mm tubule length, the GFRa1+ cell number in long continual segments over 10 mmwas counted. The
total length of counted tubule segments were 105mm (Figure 1C), 140mmofBAC-Fgf5Tg/+, 78 mm of Fgf5+/+, 94 mm of Fgf5–/–mice
(Figure 3A right), 122 mm (day10), 105 mm (day15), 94 mm (day20), 90 mm (day25), 160 mm (day30), 103 mm (day40), 100 mm
(day50), 90 mm (day60), 100 mm (day80), 73 mm (day110) of WT mice (Figure 6A), and 61 mm (day0), 106 mm (day10), 116 mm
(day15), 86 mm (day20), 91 mm (day25), 102 mm (day30), 104 mm (day40), 109 mm (day50), 104 mm (day60) of Fgf5–/– mice (Fig-
ure 6B) after busulfan treatment. In Figure 6J, the total lengths of counted tubule segments were 46 mm (+DiI in FGF5 beads),
79 mm (–DiI in FGF5 beads), 17 mm (+DiI in BSA beads), 17 mm (–DiI in BSA beads). In Figure S2E, the densities of GFRa1+ and
SOX9+ cells were counted in total 14- and 18-mm tubule segments of WT and Fgf5–/– mice. In Figures S6M and S6N, the GFRa1+
or RARg+ cell densities were counted in the following segments, 53 mm (day0), 32 mm (day3), 28 mm (day6), 29 mm (day9),
30mm (day14), 39 mm (day20), 21mm (day30). The densities of GFRa1+ or RARg+ cells were counted in the cryo-sections at Figures
3A left, 3B–3H, 6C, S2D, S3D, S3H, S4I, S4J, S4M, S6K, and S6Lwere counted by the cryo-sections. For counting the cell density per
tubule section, theGFRa1+ or RARg+ cells permore than 150 tubule sections per testes (NR 3mice) were counted byOlympus BX51
microscopy.
To assess whether spermatogonia are distributed uniformly, randomly or in a clustered fashion, we performed a statistical test,
comparing the homeostatic frequencies of spermatogonial unit numbers in bins of 1mm length along the tubule axis to a Poisson
distribution with the samemean (Figure S1A). A standard c2-test yielded a p value smaller than 105, indicating a significant deviation
from spatial randomness. Furthermore, a variance-to-mean ratio of the bin population of ðhn2i  hni2Þ=hniz3 indicated that sper-
matogonial units were more clustered rather than random or uniform. However, we could not detect any spatially regular patterns
associated with this clustering.
Measurement of Fgf5 RNA-positive cells on tubule circumference
Testicular sections were stained for Fgf5 by in situ hybridization. The tubule cross sections were photographed under bright-field
illumination, then measured the Fgf5–positive signals on tubule circumference.
Measurement of FGF5-positive signals adjacent to interstitial area or tubule bounding area
Testicular sections were double stained for FGF5 and CD34 by IF. The tubule cross sections were photographed under a confocal
microscope (Nikon A1r). The data were then analyzed to determine whether the FGF5-positive or -negative signals distributed in
the interstitial-tubule or tubule-tubule bounding regions, and then measured their lengths of FGF5- and CD34-double positive or
FGF5-negative and CD34-positive, respectively.
Scoring the distribution of GFRa1+, RARg+, KIT+ and ID4+ spermatogonia for Fgf5–positive area
Testicular sections were stained for Gfra1 or Fgf5 by ISH, or RARg, KIT, or ID4 by IHC. All the tubule cross sections were photo-
graphed. The spatial correlation with Fgf5–positive signals was judged from whether the distributions ofGfra1, RARg or KIT-positive
spermatogonia were adjacent to Fgf5+ signals on the adjacent section. When their spermatogonia were (or were not) adjacent to
Fgf5+ signals, they were categorized as ‘‘positive’’ (or ‘‘negative’’). When their spermatogonia were partially adjacent to Fgf5+ signals,
they were categorized as ‘‘boundary.’’ The category of ‘‘boundary’’ was estimated as an intermediate between ‘‘positive’’ and
‘‘negative,’’ and then the each ‘‘boundary’’ parameter was assigned to 0.5 of ‘‘positive’’ and 0.5 of ‘‘negative’’ in the determination
whether the spermatogonia distributions were adjacent to Fgf5mRNA in the category between positive or negative for the calcula-
tion. Then, expected positive numbers were calculated assuming their non-biased distributions, and the ‘preferences’ (actual pos-
itive cell number/expected positive cell number) were determined; these were statistically evaluated by chi-square test between the
actual and expected cell numbers adjacent or not to Fgf5+ area. For each data point, more than 40 seminiferous tubule cross-sec-
tions in 3 testicular slices were examined. The data were then analyzed to determine whether the distributions ofGfra1, RARg, KIT or
ID4-positive spermatogonia were adjacent to Fgf5+ signals on the adjacent section. Statistical evaluations were performed as
explained below, using the data of the Gfra1-positive spermatogonia as an example. The 3 testis specimens used for analyses
contained 91 cross-sections of the seminiferous tubules in total, and 121 Gfra1-positive spermatogonia were observed. These
121 spermatogonia were classified as ‘‘positive’’ or ‘‘negative’’ for adjacent to Fgf5+ signals on the adjacent section. The lengths
of the circumference of the tubule cross-sections were also summarized according to their levels of ISH staining of Fgf5. Then,
the expected numbers of Gfra1-positive spermatogonia in the category of positive or negative area were calculated on the basis
of the null hypothesis: the Gfra1-positive spermatogonia evenly distribute without bias. The expected numbers of Gfra1-positive
spermatogonia were obtained by multiplying the total number ofGfra1-positive spermatogonia by the percentage of tubule sections
in the category. The preferences of positive cells in each category were calculated as the ratio of the observed number of positive
cells in each category to the expected number in the same category. Thus, a preference of 1 indicates that the actual number of
Gfra1-positive cells is the same as expected, i.e., a non-biased distribution. Values greater or smaller than 1 suggest preference
or avoidance, respectively. The differences between the observed and expected numbers of Gfra1-positive spermatogonia were
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statistically evaluated by chi-square tests. The P-value (0.00002) was small enough to reject the null hypothesis and indicated a
non-random distribution of Gfra1-positive spermatogonia. This was also true for RARg but not KIT-positive spermatogonia, whose
P-values were 0.00052 and 0.13494, respectively.
Scoring the distribution of GFRa1+ and ID4+ spermatogonia for the interstitium or tubule-tubule bounding area
Testicular sections were stained for GFRa1 and ID4 by IF. The tubule cross sections were photographed by Nikon A1r confocal
system. The spatial correlation was judged from whether the distributions of GFRa1 or ID4-positive spermatogonia were adjacent
to the interstitium or tubule bounding region. When their spermatogonia were partially adjacent to the intermediate area between
the interstitium and the tubule bounding region, they were categorized as ‘‘boundary.’’
DATA AND SOFTWARE AVAILABILITY
The accession number for the microarray data reported in this study is NCBI GEO: GSE118846.
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